首页
订购/客服:400-666-5481

MTR-106

    
98.10%

5H-Benzothiazolo[3,2-a][1,8]naphthyridine-6-carboxamide, 2-[(3aR,6aS)-hexahydro-5-methylpyrrolo[3,4-c]pyrrol-2(1H)-yl]-N-[(5-methyl-2-pyrazinyl)methyl]-5-oxo-, rel-

源叶(MedMol)
S89223 一键复制产品信息
1639357-93-9
C28H27N7O2S
525.62
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S89223-5mg买3赠1
98.10%

¥650.00

6 - - - -
S89223-10mg买3赠1
98.10%

¥1000.00

5 - - - -
S89223-25mg买3赠1
98.10%

¥2000.00

6 - - - -
S89223-100mg
≥98%

¥6200.00

货期:2-3天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: ZYN57939 is RNA polymerase I inhibitor for treating RNA polymerase I- mediated diseases. ZYN57939 showed inhibitory activity with IC50 of 0.855 μM against human HT- 29 cancer cell lines.
靶点: DNA/RNA Synthesis;DNA/RNASynthesis
体内研究: MTR-106 oral and i.v. administration significantly impaired tumor growth in BRCA-deficient xenograft mouse models.?However, MTR-106 showed modest activity against talazoparib-resistant xenograft models.In rats, the drug rapidly distributes to tissues within 5 min, and its average concentrations were 12-fold higher in the tissues than in the plasma.Overall, MTR-106 as a novel G-quadruplex stabilizer with high tissue distribution, and it may serve as a potential anticancer agent.
参考文献: 1. Discovery of MTR-106 as a highly potent G-quadruplex stabilizer for treating BRCA-deficient cancers[J]. Investigational New Drugs, 2021:1-9.
溶解性: Soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 1.903 ml 9.513 ml 19.025 ml
5 mM 0.381 ml 1.903 ml 3.805 ml
10 mM 0.19 ml 0.951 ml 1.903 ml
50 mM 0.038 ml 0.19 ml 0.381 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×